Helix Biopharma Corp
F:HBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Helix Biopharma Corp
F:HBP
|
CA |
|
B
|
Boiron SA
XMUN:BON
|
FR |
|
Hillcrest Energy Technologies Ltd
F:7HI
|
CA |
|
Celon Pharma SA
F:8RP
|
PL |
|
Live Motion Games SA
F:4YM
|
PL |
|
Asia Air Survey Co Ltd
OTC:AASLF
|
JP |
|
Sintana Energy Inc
OTC:SEUSF
|
CA |
|
E
|
Eisai Co Ltd
XBER:EII
|
JP |
|
Xali Gold Corp
F:I970
|
CA |
|
J
|
Japan Logistics Fund Inc
F:8UT
|
JP |
|
K
|
KH Group Oyj
SWB:WE3
|
FI |
|
P
|
Platinum Group Metals Ltd
F:P6MB
|
CA |
|
C
|
China Evergrande Group
XBER:EV1
|
CN |
|
Subaru Corp
TSE:7270
|
JP |
|
Iida Group Holdings Co Ltd
F:IIO
|
JP |
|
Shoei Co Ltd
OTC:SHOFF
|
JP |
|
Yamaguchi Financial Group Inc
F:5FW
|
JP |
|
Logiq Inc
F:G8UX
|
US |
|
M
|
Mincor Resources NL
F:MV3
|
AU |
|
Y
|
Yokogawa Electric Corp
F:YKE
|
JP |
Bankruptcy Probability
Helix Biopharma Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Helix Biopharma Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Helix Biopharma Corp
TSX:HBP
|
148.2m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
464.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
238.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
59.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Helix Biopharma Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Helix Biopharma Corp has total debt of 359k CAD. This includes both short-term (359k CAD) and long-term (0 CAD) debt.
You can find a full breakdown on its Balance Sheet.
